Jounce Therapeutics Other Current Assets

Jounce Therapeutics (JNCE) currently reports a other current assets of $7.7M as of December 2022. That compares with $12M in the prior-year period — down 37.3% year over year. Use the charts on this page to explore Jounce Therapeutics's other current assets history and peer comparisons.

Jounce Therapeutics's other current assets decreased from $12M to $7.7M — a 37.3% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Jounce Therapeutics reported $7.7M in other current assets as of December 2022. That compares with $12M in the prior-year period — down 37.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $7.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Jounce Therapeutics, and consider following JNCE for alerts when major investors trade the stock.

Jounce Therapeutics is classified in the Healthcare sector. On other current assets, it currently shows $7.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing JNCE with unrelated industries.